Last reviewed · How we verify
NCT02947464: ERMES
Rapid Maxillary Expansion for Residual Pediatric
NA trial testing Standard clinical practice in Obstructive Sleep Apnea in 16 participants. Completed in 30 June 2021.
30 May 2021
Quick facts
| Lead sponsor | Basque Health Service |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 10 January 2018 |
| Primary completion | 30 May 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Standard clinical practice
- Standard clinical practice + Rapid Maxillary Expansion
Conditions studied
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
Sponsor
Basque Health Service — full company profile →
Who can join
Adults 4 to 9, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized Controlled Trial comparing Rapid Maxillary Expansion with Standard Clinical Practice in patients with residual pediatric Obstructive Sleep Apnea Syndrome after adenotonsillectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02947464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard clinical practice
Trials testing the same drug.
- NCT04985279 — Position and Angle Marking System (PAMS) for Ultrasound-guided Neuraxial Procedures · NA · unknown
Other recruiting trials for Obstructive Sleep Apnea
Currently open trials in the same condition.
- NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
- NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
- NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting
Other Basque Health Service trials
Trials by the same sponsor.
- NCT06437444 — Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care · NA · recruiting
- NCT04022850 — De-implementation of Low-value Pharmacological Prescriptions · NA · completed
- NCT04658706 — The SEHNeCa Supervised Exercise Project · NA · unknown
- NCT04159623 — Clinical Applicability of the Device Belk in the Rehabilitation Process · NA · completed
- NCT04602182 — Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02947464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Basque Health Service
- Last refreshed: 20 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02947464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing